Novo Nordisk | NVO - Efectivo Y Equivalentes

Precio De Mercado
37.97
Cambio Diario
0.55 1.47%
Mensual
-2.19%
Anual
-41.33%
Q2 Expectativa
35.64




Efectivo Y Equivalentes Cambio Fecha
ANI Pharmaceuticals USD 285.58M 22.98M 2025-12
Aurora Cannabis CAD 56.36M 39.33M 2025-12
Bausch Health Companies USD 1.31B 419M 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Canopy Growth CAD 371.32M 73.26M 2025-12
Corcept Therapeutics USD 120.49M 4.64M 2025-12
Drreddys Laboratories INR 18.66B 9.65B 2025-12
Eli Lilly USD 7.27B 2.52B 2025-12
GlaxoSmithKline GBP 3.3B 303M 2025-09
Merck USD 18.17B 10.16B 2025-09
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Novartis USD 9.56B 2.9B 2025-09
Novo Nordisk DKK 38.94B 24.15B 2025-03
Novo Nordisk A/S DKK 18.44B 5.78B 2025-06
Pacira USD 158.54M 10.96M 2025-12
Perrigo USD 432.1M 22.1M 2025-09
Phibro Animal Health USD 55.49M 17.28M 2025-12
Prestige Brands USD 62.37M 56.73M 2025-12
Sanofi EUR 7.66B 1.25B 2025-12
Supernus Pharmaceuticals USD 151.37M 6.66M 2025-09
Zoetis USD 2.08B 649M 2025-09